MXCT vs PNC · rev $38.6M vs P/E 14, rev $23.10B
MaxCyte Inc (MXCT) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported PNC revenue for 2025-12-31 was $23.10B. Net income was $7.00B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
MXCT currently screens at market cap $124.3M. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the MXCT and PNC stock pages for the full models.
Not investment advice.